A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation

por Akil, Ayman, Bies, Robert R., Pollock, Bruce G., Avramopoulos, Dimitrios, Devanand, D. P., Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Weintraub, Daniel, Yesavage, Jerome, Shade, David M., Lyketsos, Constantine G.
Publicado 2015

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate

por van Dyck, Christopher H., Arnsten, Amy F.T., Padala, Prasad R., Brawman-Mintzer, Olga, Lerner, Alan J., Porsteinsson, Anton P., Scherer, Roberta W., Levey, Allan I., Herrmann, Nathan, Jamil, Nimra, Mintzer, Jacobo E., Lanctôt, Krista L., Rosenberg, Paul B.
Publicado 2020

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloi...

por Spira, Adam P, Zipunnikov, Vadim, Raman, Rema, Choi, Jiyoon, Di, Junrui, Bai, Jiawei, Carlsson, Cynthia M, Mintzer, Jacobo E, Marshall, Gad A, Porsteinsson, Anton P, Yaari, Roy, Wanigatunga, Sarah K, Kim, John, Wu, Mark N, Aisen, Paul S, Sperling, Reisa A, Rosenberg, Paul B
Publicado 2021

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014